← Back to Search

CTR-US for Carpal Tunnel Syndrome (MISSION Trial)

N/A
Recruiting
Led By Victor M Marwin, MD, MBA
Research Sponsored by Sonex Health, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

MISSION Trial Summary

Multicenter prospective registry of patients with symptomatic Carpal Tunnel Syndrome treated with Ultrasound Guided Carpal Tunnel Release (CTR-US).

Eligible Conditions
  • Carpal Tunnel Syndrome
  • CT Scan

MISSION Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Boston Carpal Tunnel Questionnaire - Symptom Severity Scale (BCTQ-SSS)
Secondary outcome measures
Boston Carpal Tunnel Questionnaire - Functional Status Scale (BCTQ-FSS)
Device and/or Procedure Related Adverse Events
EuroQoL 5-Dimension 5-Level (EQ-5D-5L)
+4 more

MISSION Trial Design

1Treatment groups
Experimental Treatment
Group I: CTR-USExperimental Treatment1 Intervention
Ultrasound Guided Carpal Tunnel Release (CTR-US)

Find a Location

Who is running the clinical trial?

Sonex Health, Inc.Lead Sponsor
3 Previous Clinical Trials
682 Total Patients Enrolled
3 Trials studying Carpal Tunnel Syndrome
682 Patients Enrolled for Carpal Tunnel Syndrome
Victor M Marwin, MD, MBAPrincipal InvestigatorBluegrass Orthopaedics

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1333 spots leftby Dec 2027